Coenzyme Q10, Glucose Homeostasis and the Probable Mediating Role of Adipokines

Authors

  • Mohammad Javad Hosseinzadeh-Attar, MD, PhD
  • Elham Alipoor, MSc
  • Parvaneh Mehrdadi, MSc

DOI:

https://doi.org/10.17140/OROJ-3-e008

Keywords:

diabetes, heart failure, hypertension, and Parkinson disease

Abstract

Coenzyme Q10 is one of the most popular nutritional supplements, which has been discovered
in 1955. It is also known as ubiquinone, Q10, CoQ and vitamin Q10. This coenzyme has two
isoforms; the oxidized form, ubiquinone, is an electron carrier in mitochondrial respiratory
chain and the reduced form, ubiquinol, acts as an antioxidant.1,2 Studies reported its beneficial
effects in some diseases such as diabetes, heart failure, hypertension, and Parkinson disease.3,4
Q10 has also been proposed to be helpful in prevention and treatment of neurodegenerative
and mitochondrial related diseases.5
Q10 could potentially be effective on metabolic disorders
including lipid profile, blood pressure, glycemic control and insulin resistance in different diseases

References

Young AJ, Johnson S, Steffens DC, Doraiswamy PM. Coenzyme Q10: a review of its promise as a neuroprotectant. CNS Spectr. 2007; 12(1): 62-68. doi: 10.1017/S1092852900020538

Crane FL. Biochemical functions of coenzyme Q10. J Am Coll Nutr. 2001; 20(6): 591-598. doi: 10.1080/07315724.2001.10719063

Dhanasekaran M, Ren J. The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus. Curr Neurovasc Res. 2005; 2(5): 447-459. doi: 10.2174/156720205774962656

Khatta M, Alexander BS, Krichten CM, et al. The effect of coenzyme Q10 in patients with congestive heart failure. Ann Intern Med. 2000; 132(8): 636-640. doi: 10.7326/0003-4819-132-8-200004180-00006

Beal MF. Therapeutic effects of coenzyme Q 10 in neurodegenerative diseases. Methods Enzymol. 2004; 382: 473-487. doi: 10.1016/S0076-6879(04)82026-3

Kolahdouz MR, Hosseinzadeh-Attar M, Eshraghian M, Nakhjavani M, Khorami E, Esteghamati A. The effect of coenzyme Q10 supplementation on metabolic status of type 2 diabetic patients. Minerva Gastroenterol Dietol. 2013; 59(2): 231-236. Web site. http://europepmc.org/abstract/med/23831913. Accessed April 19, 2016

Hodgson J, Watts G, Playford D, Burke V, Croft K. Original communication-coenzyme Q10 improves blood pressure and glycae-mic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr. 2002; 56(11): 1137-1142. doi: 10.1038/sj.ejcn.1601464

Singh R, Niaz M, Rastogi S, Shukla P, Thakur A. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery. J Hum Hypertens. 1999; 13(3): 203-208.

Semple RK. EJE PRIZE 2015: How does insulin resistance arise, and how does it cause disease? Human genetic lessons. Eur J Endocrinol. 2016; 174(5): R209-R223. doi: 10.1530/EJE-15-1131

Whiteman EL, Cho H, Birnbaum MJ. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab. 2002; 13(10): 444- 451. doi: 10.1016/S1043-2760(02)00662-8

Amin MM, Asaad GF, Salam RMA, El-Abhar HS, Arbid MS. Novel CoQ10 antidiabetic mechanisms underlie its positive ef-fect: modulation of insulin and adiponectine receptors, tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats. PloS one. 2014; 9(2): e89169. doi: 10.1371/journal.pone.0089169

Zahedi H, Eghtesadi S, Seifirad S, et al. Effects of CoQ10 supplementation on lipid profiles and glycemic control in patients with type 2 diabetes: a randomized, double blind, placebo-controlled trial. J Diabetes Metab Disord. 2014; 13(1): 1-8. doi: 10.1186/ s40200-014-0081-6

Sena CM, Nunes E, Gomes A, et al. Supplementation of coenzyme Q 10 and α-tocopherol lowers glycated hemoglobin level and lipid peroxidation in pancreas of diabetic rats. Nutr Res. 2008; 28(2): 113-121. doi: 10.1016/j.nutres.2007.12.005

Mezawa M, Takemoto M, Onishi S, et al. The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: an open label pilot study. Biofactors. 2012; 38(6): 416-421. doi: 10.1002/biof.1038

Amin MM, Asaad GF, Abdel Salam RM, El-Abhar HS, Arbid MS. Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats. PloS one. 2014; 9(2): e89169. doi: 10.1371/journal.pone.0089169

Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006; 444(7121): 840-846. doi: 10.1038/nature05482

Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 2007; 21(12): 1443-1455. doi: 10.1101/gad.1550907

Yadav A, Kataria MA, Saini V, Yadav A. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta. 2013; 417: 80-84. doi: 10.1016/j.cca.2012.12.007

Stofkova A. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr Regul. 2010; 44(1): 25- 36. Web site. http://europepmc.org/abstract/med/20151765. Accessed April 19, 2016

Denroche HC, Huynh FK, Kieffer TJ. The role of leptin in glucose homeostasis. J Diabetes Investig. 2012; 3(2): 115-129. doi: 10.1111/j.2040-1124.2012.00203.x

Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005; 365(9467): 1333-1346. doi: 10.1016/S0140-6736(05)61032-X

Nedvidkova J, Smitka K, Kopsky V, Hainer V. Adiponectin, an adipocyte-derived protein. Physiol Res. 2005; 54(2): 133-140. Web site. http://search.proquest.com/openview/2443a3956e202092b6c8241770459c20/1?pq-origsite=gscholar. Accessed April 19, 2016

Wei Z, Peterson JM, Lei X, et al. C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitiv-ity and glycemic control in mouse models of obesity and diabetes. J Biol Chem. 2012; 287(13): 10301-10315. doi: 10.1074/jbc. M111.303651

Enomoto T, Ohashi K, Shibata R, et al. Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose me-tabolism. J Biol Chem. 2011; 286(40): 34552-34558. doi: 10.1074/jbc.M111.277319

Downloads

Published

2016-04-25

How to Cite

Mohammad Javad Hosseinzadeh-Attar, MD, PhD, Elham Alipoor, MSc, & Parvaneh Mehrdadi, MSc. (2016). Coenzyme Q10, Glucose Homeostasis and the Probable Mediating Role of Adipokines. Obesity Research, 20–22. https://doi.org/10.17140/OROJ-3-e008

Issue

Volume 3 Issue 1 2016

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Obesity Research (OR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.